Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 11,121,954
- Share change
- +280,756
- Total reported value
- $62,947,464
- Price per share
- $5.65
- Number of holders
- 27
- Value change
- +$1,581,064
- Number of buys
- 13
- Number of sells
- 11
Report period
Q4 2019
Institutions
27
Top holders
10
SCPH full security history
Newer quarter: Q1 2020
Previous quarter: Q3 2019
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 810648105
Recent filing periods:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$20,016,000 | — | 30 Sep 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.1%
|
3,247,005
|
$19,060,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
256,133
|
$1,516,000 | — | 30 Sep 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.42%
|
221,636
|
$1,301,003 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.21%
|
112,131
|
$658,000 | — | 30 Sep 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
61,500
|
$364,000 | — | 30 Sep 2019 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.1%
|
55,814
|
$328,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
49,923
|
$293,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
47,489
|
$281,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
32,683
|
$193,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
17,590
|
$104,000 | — | 30 Sep 2019 | |
| Matisse Capital |
13F
|
Company |
0.03%
|
14,685
|
$86,000 | — | 30 Sep 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.03%
|
14,634
|
$86,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
10,426
|
$62,000 | — | 30 Sep 2019 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
10,268
|
$60,000 | — | 30 Sep 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
8,884
|
$53,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
1,806
|
$11,000 | — | 30 Sep 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,300
|
$8,000 | — | 30 Sep 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
1,090
|
$6,000 | — | 30 Sep 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
768
|
$4,547 | — | 30 Sep 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
767
|
$5,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
742
|
$4,000 | — | 30 Sep 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
357
|
$2,000 | — | 30 Sep 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
142
|
$1,000 | — | 30 Sep 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
42
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q4 2019
As of 31 Dec 2019,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,121,954 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Squarepoint Ops LLC, and Alambic Investment Management, L.P..
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
24
Q4 2019 holders
27
Holder diff
3
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.